Company News
Apogee Therapeutics Gains 16% on $1.3B Blackstone Deal
Apogee Therapeutics shares rose about 16% pre‑market after announcing a $1.3 billion financing deal with Blackstone Life Sciences.
The agreement provides up to $800 million synthetic royalty funding a
